Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
Files
Publication date
2015-11
Authors
Knol, Mirjam J
Wagenvoort, Gertjan H J
Sanders, Lieke
Elberse, Karin
Vlaminckx, Bart
de Melker, Hester E
van der Ende, Arie
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
Three years after a 7-valent pneumococcal conjugate vaccine was replaced by a 10-valent pneumococcal conjugate vaccine in the Netherlands, we observed a decrease in incidence of invasive pneumococcal disease caused by Streptococcus pneumoniae serotypes 1, 5, and 7F. Our data do not support or exclude cross-protection against serotype 19A.
Keywords
RANDOMIZED-CONTROLLED-TRIAL, PHID-CV, IMMUNOGENICITY, Journal Article
Citation
Knol, M J, Wagenvoort, G H J, Sanders, E A M, Elberse, K, Vlaminckx, B J, de Melker, H E & van der Ende, A 2015, 'Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands', Emerging Infectious Diseases, vol. 21, no. 11, pp. 2040-2044. https://doi.org/10.3201/eid2111.140780